Amakem Therapeutics (Formerly Known As Amakem NV)
BioVille
Agoralaan bldg. A bis
3590
Diepenbeek
Tel: 32-0-11-286-982
Fax: 32-0-11-490-209
Website: http://www.amakem.com/
Email: info@amakem.com
10 articles about Amakem Therapeutics (Formerly Known As Amakem NV)
-
Amakem Therapeutics Appoints Dr. James Tsai Of The Yale School Of Medicine To Its Clinical Advisory Board
3/4/2014
-
Amakem NV to Present Top-Line Clinical Results for its Lead Candidate, AMA0076, at Ophthalmology Innovation Summit at the American Academy of Ophthalmology Meeting 2013
11/7/2013
-
Amakem NV Appoints Jean Marie Stassen as Vice President, Research and Development
9/3/2013
-
Amakem NV Appoints Kieran Rooney as Vice President, Business Development
6/24/2013
-
Amakem NV Sponsors Ophthalmology Chair at KU Leuve
4/8/2013
-
Amakem NV Appoints Dr. Steve Pakola as Chief Medical Officer; Dr. George Lasezkay Joins Board of Directors
5/11/2012
-
Amakem NV Presents AMA0076 Data at the 2012 ARVO Annual Meeting
5/8/2012
-
Amakem NV Recruits Leading Ophthalmology Experts to Clinical Advisory Board
3/20/2012
-
Amakem NV Announces Further Proof-of-Concept Results for Its "Localized Drug Action" Platform
11/2/2011
-
Amakem NV Raises $25.3 Million to Take Glaucoma Candidate Through Phase II Trials
9/6/2011